By leveraging its proprietary technology platform VECT-HORUS has developed a hybrid business model.

Internal pipeline of proprietary drug candidates

VECT-HORUS is building a pipeline of proprietary drug candidates for internal development up to until preclinical or early clinical trials. These products are available for licensing-out.

External collaborations with partners

VECT-HORUS’ highly innovative technology platform is available to pharmaceutical and biotech partners to transport their drugs into the brain and other organs. The Company has combined solid competences and expertise in various R&D areas and has set up well-structured and state of the art technological platforms. The Company has various ongoing collaborations in different domains (CNS, NDD, cancer imaging and treatment, etc.).